Nexgel Inc (NXGL)
NEXGEL, Inc. is a healthcare company listed on the NASDAQ under the ticker NXGL. The company develops, manufactures, and sells high-water-content hydrogels and gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. Its business is organized into two segments, Nexgel and CG Labs, and it also provides converting and packaging services.
The company’s product range includes over-the-counter blister and pain relief applications as well as beauty and cosmetic solutions. NEXGEL is also developing NEXDrape, an incise surgical drape intended for patients with impaired skin, and NEXDerm, an adhesive tape designed to help secure central lines, IV tubes, and other medical devices during treatment. Its products are sold under the Medagel, Lumagel Beauty, Kenkoderm, and Silly George brand names. Founded in 2009 and based in Langhorne, Pennsylvania, the company was previously known as AquaMed Technologies, Inc. before changing its name in 2019.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NXGL
|
$0.68
|
50.4% Upside
|
Bargain
|
$2
|
342.5% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 18, 2026
|
-1.3x
|
1.0x
|
0.4x
|
4.068 M
|
8.444 M
|
48.4%
|
77.5%
|
-2.5
|
—
|
46.4%
|
